Aerial image of the facility
Key Statistics
Client
MSD
Year
2021
PM Group Office
Belgium & Cork
Cost
€250m
Size
15,000 sq.m.

MSD is a leading global biopharmaceutical manufacturer and the largest pharmaceutical company in the Netherlands. The company is substantially expanding its vaccine manufacturing capacity to meet the growing worldwide demand.

State-of-the-art facility

This new brownfield development at MSD’s existing Boxmeer site incorporates advanced technology to provide additional production capacity for sterile filling and freeze drying of vaccines. The facility also incorporates a utilities building and associated infrastructure, with capacity for future expansion.

PM Group’s services on the project included full project lifecycle design, procurement, construction and CQV.  

Collaboration for safety performance

At peak construction, over 450 people entered the project site daily. The workforce came from over 25 countries including Iran, Iraq, Kazakhstan, North Africa and Europe.

Aerial image - 1 million Safe Hours milestone

With such a broad cultural workforce, managing a safe site posed many obstacles. However the main project contractors from the Netherlands, Ireland, Belgium, Germany, Austria and Serbia overcame the challenges with their strong commitment to and collaboration for safety. Also paramount to the successful safety record achieved on this project was the commitment and leadership by PM Group’s design, construction management and CQV teams.